Stockscreener 앱 받기
2.18
2.68%
-0.06
시간 외 거래:
2.20
0.02
+0.92%
전일 마감가:
$2.24
열려 있는:
$2.19
하루 거래량:
9.46M
Relative Volume:
0.67
시가총액:
$788.84M
수익:
$241.53M
순이익/손실:
$-389.92M
주가수익비율:
-1.7724
EPS:
-1.23
순현금흐름:
$-323.54M
1주 성능:
+3.81%
1개월 성능:
-1.80%
6개월 성능:
-28.76%
1년 성능:
-78.56%
1일 변동 폭
$2.13
$2.24
1주일 범위
$2.09
$2.31
52주 변동 폭
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
명칭
Iovance Biotherapeutics Inc
전화
(650) 260-7120
주소
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
2.18 | 810.55M | 241.53M | -389.92M | -323.54M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-05-12 | 다운그레이드 | Truist | Buy → Hold |
| 2025-05-09 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-07-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-09-18 | 재확인 | Barclays | Overweight |
| 2023-05-30 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 재개 | Wells Fargo | Equal Weight |
| 2023-01-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-31 | 개시 | Guggenheim | Neutral |
| 2022-08-18 | 재개 | Wells Fargo | Equal Weight |
| 2022-01-28 | 업그레이드 | Stifel | Hold → Buy |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2021-06-10 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-05-03 | 개시 | Truist | Buy |
| 2021-04-16 | 개시 | Goldman | Buy |
| 2021-03-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 개시 | Mizuho | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-02-26 | 재확인 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
| 2019-10-01 | 개시 | Stifel | Buy |
| 2019-04-29 | 개시 | Piper Jaffray | Overweight |
| 2019-02-28 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-07 | 개시 | Robert W. Baird | Outperform |
| 2018-12-31 | 재개 | B. Riley FBR | Buy |
| 2018-07-06 | 재확인 | Chardan Capital Markets | Buy |
| 2018-04-10 | 업그레이드 | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 재확인 | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-01 | 재확인 | B. Riley FBR, Inc. | Buy |
모두보기
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
62,790 Options: Iovance Grants Inducement Awards to Nine New Hires at $2.24 Strike, 3-Year Vesting - Stock Titan
Can Iovance Biotherapeutics Inc. stock outperform in 2025 bull marketJuly 2025 WrapUp & Smart Allocation Stock Tips - Trung tâm Dự báo KTTV quốc gia
Why Iovance Biotherapeutics Inc. stock appeals to analystsShort Setup & Low Drawdown Momentum Ideas - newser.com
EV Market: What is the fair value of Iovance Biotherapeutics Inc. stock now2025 Price Targets & Free Safe Capital Growth Stock Tips - Trung tâm Dự báo KTTV quốc gia
Using R and stats models for Iovance Biotherapeutics Inc. forecastingEarnings Trend Report & Technical Buy Zone Confirmation - newser.com
Better Beaten-Down Stock: Iovance Biotherapeutics vs. Teladoc Health - The Globe and Mail
How Iovance Biotherapeutics Inc. stock performs during Fed tightening cyclesForecast Cut & Short-Term Trading Alerts - newser.com
Why Iovance Biotherapeutics Inc. stock is favored by top institutionsIPO Watch & Reliable Entry Point Alerts - newser.com
Does Iovance Biotherapeutics Inc. stock trade at a discount to peersPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Identifying reversal signals in Iovance Biotherapeutics Inc.Earnings Summary Report & AI Driven Price Predictions - newser.com
Why Iovance Biotherapeutics Inc. (2LB) stock fits value portfoliosJuly 2025 Rallies & Fast Exit and Entry Strategy Plans - newser.com
Is Iovance Biotherapeutics Inc. (2LB) stock positioned for digital growth eraRecession Risk & Real-Time Market Trend Scan - newser.com
Using flow based indicators on Iovance Biotherapeutics Inc.July 2025 Movers & Technical Pattern Based Buy Signals - newser.com
Is Iovance Biotherapeutics Inc. stock a good choice for value investorsJuly 2025 PostEarnings & Consistent Return Investment Signals - newser.com
Iovance Biotherapeutics Inc. stock prediction for this weekEarnings Risk Summary & Real-Time Price Movement Reports - newser.com
Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire? - AOL.com
Signal strength of Iovance Biotherapeutics Inc. stock in tech scannersInsider Selling & Smart Allocation Stock Tips - newser.com
Iovance: Q3 Earnings May Smart, But Long Term Bull Thesis Remains In Play (IOVA) - Seeking Alpha
How supply shortages influence Iovance Biotherapeutics Inc. (2LB) stockGap Up & High Yield Stock Recommendations - newser.com
Real time breakdown of Iovance Biotherapeutics Inc. stock performanceJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Why Iovance Biotherapeutics Inc. (2LB) stock signals breakout potential - newser.com
Iovance Biotherapeutics (NASDAQ:IOVA) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Iovance Biotherapeutics Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues - GlobeNewswire
Iovance Biotherapeutics (NASDAQ:IOVA) Trading Up 6.7%What's Next? - MarketBeat
Iovance Biotherapeutics Inc Stock Analysis and ForecastIndustrial Stocks Review & Stay Ahead With Daily Market Discussions - earlytimes.in
The Bull Case For Iovance Biotherapeutics (IOVA) Could Change Following Global Regulatory Push—Learn Why - Sahm
Iovance Biotherapeutics (NASDAQ:IOVA) Stock Price Down 4.5%Should You Sell? - MarketBeat
Iovance Biotherapeutics (IOVA): Examining Valuation as Share Price Momentum Stalls - Yahoo Finance
Will Iovance Biotherapeutics Inc. rebound enough to break evenAnalyst Downgrade & Safe Entry Trade Signal Reports - newser.com
Will Iovance Biotherapeutics Inc. (2LB) stock announce special dividendMarket Sentiment Report & Weekly Top Performers Watchlists - newser.com
Iovance Biotherapeutics Inc (IOVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.50%
자본화:
|
볼륨(24시간):